News & Analysis as of

Endo Pharmaceuticals Patent Litigation

Robins Kaplan LLP

Endo Pharm., Inc. v. Actavis LLC

Robins Kaplan LLP on

Case Name: Endo Pharm., Inc. v. Actavis LLC, No. 2018-1054, 2019 U.S. App. LEXIS 13348 (Fed. Cir. May 3, 2019) (Circuit Judges Wallach, Clevenger, and Stoll presiding; Opinion by Wallach; Dissent by Stoll) (Appeal from D....more

Robins Kaplan LLP

Endo Pharms. Inc. v. Teva Pharms. USA, Inc.

Robins Kaplan LLP on

Case Name: Endo Pharms. Inc. v. Teva Pharms. USA, Inc., C.A. No. 17-1240, 1455, 1887, 2019 U.S. App. LEXIS 9189 (Fed. Cir. Mar. 28, 2019)....more

Foley & Lardner LLP

Federal Circuit Finds Endo Method Of Treatment Claims Satisfy 35 USC 101

Foley & Lardner LLP on

In Endo Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc., the Federal Circuit distinguished method of treatment claims that involve personalized dosing from the claims invalidated in Mayo v. Prometheus, and found them...more

Robins Kaplan LLP

Endo Pharms. Sols., Inc. v. Custopharm Inc.

Robins Kaplan LLP on

Case Name: Endo Pharms. Sols., Inc. v. Custopharm Inc., 894 F.3d 1374, 2018 U.S. App. LEXIS 19265 (Fed. Cir. July 13, 2018) (Circuit Judges Moore, Linn, and Chen presiding; Opinion by Chen, J.) (Appeal from D. Del., Robinson,...more

Robins Kaplan LLP

Endo Pharms. Inc. v. Teva Pharms. USA, Inc.

Robins Kaplan LLP on

Case Name: Endo Pharms. Inc. v. Teva Pharms. USA, Inc., Fed. Cir. Nos. 2015-2021, -2022, -2023, -2024, -2025, -2026, -2028, -2031, -2033, -2034, -2035, -2041, -2042, -2046, -2047, -2049, -2059, -2060, 2016-1025, -1060, -1117,...more

Robins Kaplan LLP

Endo Pharma. Solutions Inc. v. Custopharm, Inc.

Robins Kaplan LLP on

Case Name: Endo Pharma. Solutions Inc. v. Custopharm, Inc., 14-1422-SLR, 2017 U.S. Dist. LEXIS 19035 (D. Del. Feb. 10, 2017) (Robinson, J.). Drug Product and Patent(s)-in-Suit: Aveed® (testosterone undecanoate); U.S....more

Robins Kaplan LLP

Endo Pharms. Inc. v. Amneal Pharms. LLC

Robins Kaplan LLP on

Case Name: Endo Pharms. Inc. v. Amneal Pharms. LLC, Civ Nos. 14-1382-RGA, 14-1389-RGA, 2016 U.S. Dist. LEXIS 140112 (D. Del. Oct. 7, 2016) (Andrews, J.). Drug Product and Patent(s)-in-Suit: Opana® ER (oxymorphone...more

Robins Kaplan LLP

Endo Pharms. Inc. v. Actavis Labs. UT, Inc.

Robins Kaplan LLP on

Case Name: Endo Pharms. Inc. v. Actavis Labs. UT, Inc., 2016-1146, 2016 U.S. App. LEXIS 18490 (Fed. Cir. Oct. 14, 2016) (Circuit Judges Moore, Taranto, and Hughes presiding; Opinion by Taranto, J.) (Appeal from E.D. Tex.,...more

Robins Kaplan LLP

Endo Pharm. Inc. v. Amneal Pharms. LLC

Robins Kaplan LLP on

Case Name: Endo Pharm. Inc. v. Amneal Pharms. LLC, Civil Nos. 12 Civ. 8115 (TPG),12 Civ. 8060 (TPG),12 Civ. 8317 (TPG),12 Civ. 8985 (TPG),13 Civ. 435 (TPG),13 Civ. 436 (TPG),13 Civ. 3288 (TPG),13 Civ. 4343 (TPG),13 Civ. 8597...more

McDonnell Boehnen Hulbert & Berghoff LLP

Top Stories of 2015: #16 to #20

After reflecting upon the events of the past twelve months, Patent Docs presents its ninth annual list of top patent stories. For 2015, we identified twenty stories that were covered on Patent Docs last year that we believe...more

McDonnell Boehnen Hulbert & Berghoff LLP

Endo Pharmaceuticals Inc. v. Actavis Inc. (D. Del. 2015)

District Court Adopts Magistrate's Conclusion of Invalidity under § 101 and Grants Defendants' Motion to Dismiss Counts - Last month, in Endo Pharmaceuticals Inc. v. Actavis Inc., Judge Richard G. Andrews of the U.S....more

Robins Kaplan LLP

Endo Pharms. Inc. v. Amneal Pharms. LLC

Robins Kaplan LLP on

Case Name: Endo Pharms. Inc. v. Amneal Pharms. LLC, Civ. Nos. 12 Civ. 8115 (TPG), 12 Civ. 8060 (TPG), 12 Civ. 8317 (TPG), 12 Civ. 8985 (TPG), 13 Civ. 435 (TPG), 13 Civ. 436 (TPG), 13 Civ. 3288 (TPG), 13 Civ. 4343 (TPG), 13...more

Robins Kaplan LLP

Endo Pharms. Inc. v. Actavis Inc.

Robins Kaplan LLP on

Case Name: Endo Pharms. Inc. v. Actavis Inc., Civ. No. 14-1381-RGA, 2015 U.S. Dist. LEXIS 127104 (D. Del. Sept. 23, 2015) (Thynge, M.J.) - Drug Product and Patent(s)-in-Suit: Opana ER® (oxymorphone); U.S. Patent No...more

Robins Kaplan LLP

1+ year delay post-answer in counterclaiming for invalidity and non-infringement is acceptable under Rule 15

Robins Kaplan LLP on

Endo Pharmaceuticals, Inc. and Grüenthal GmbH v. Teva Pharmaceuticals USA, Inc. and Barr Laboratories, Inc. Case Number: 1:12-cv-08060-TPG-GWG - Teva delayed more than one year between answering a complaint...more

Robins Kaplan LLP

Judge Griesa declines to revisit Federal Circuit’s finding that a license and settlement agreement is “clear on its face.”

Robins Kaplan LLP on

Endo Pharmaceuticals, Inc. v. Roxane Laboratories, Inc. Case Number: 1:13-cv-03288-TPG - Defendant Roxane Laboratories, Inc. (“Roxane”) was sued by Endo Pharmaceuticals, Inc. (“Endo”) when Endo learned that...more

McDonnell Boehnen Hulbert & Berghoff LLP

Court Report - November 2014 #2

About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. AstraZeneca Pharmaceuticals LP et al. v. Pharmadax USA, Inc. et al. 1:14-cv-07105; filed November 3, 2014 in the...more

Robins Kaplan LLP

Judicial Efficiencies and Economy Support Bifurcation of Liability and Damages at Trial

Robins Kaplan LLP on

Endo Pharmaceuticals, Inc. v. Actavis, Inc., et al. Case Number: 1:12-cv-08985-TPG (Dkt.55) - Endo brought suit against Actavis, as well as over a dozen other pharmaceutical manufacturers, for allegedly...more

Robins Kaplan LLP

Judge Griesa Orders Parties to Brief Whether a Patent Prosecution Bar Prevents Defense Counsel From Participating in an Inter...

Robins Kaplan LLP on

Endo Pharmaceuticals Inc. et al. v. Teva Pharmaceuticals USA, Inc. et al. Inter Partes Review. Case Number: 1:12-cv-08060-GWG (Dkt. 68) - One of twelve defendants in patent suits brought by Endo petitioned the...more

Robins Kaplan LLP

Endo Pharms. Inc. v. Actavis, Inc. (Fed Cir)

Robins Kaplan LLP on

Case Name: Endo Pharms. Inc. v. Actavis, Inc., Nos. 2013-1658, -1662, 2014 U.S. App. LEXIS 5879 (Fed. Cir. Mar. 31, 2014) (Circuit Judges Newman, Dyk, and Moore presiding; Opinion by Moore, J.; Dissent-in-part by Dyk) (appeal...more

McDermott Will & Emery

Implied License Limited to Continuation Applications, Not to Provisionals

Endo Pharmaceuticals Inc. v. Actavis, Inc. - Addressing the issue of implied license, the U.S. Court of Appeals for the Federal Circuit vacated and remanded a lower court’s denial of a preliminary injunction, finding...more

Robins Kaplan LLP

Expert Who Files Patent Applications Not Barred From Receiving Confidential Information - Endo Pharmaceuticals Inc. et al v. Par...

Robins Kaplan LLP on

Case Number: 1:12-cv-09261-TPG (Dkt. 76) - The court denied plaintiffs’ motion to bar Par’s expert Professor Midian from receiving any of their confidential information unless he agreed to a patent prosecution bar. ...more

21 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide